Indicated for the treatment of chronic Hepatitis C (CHC) in adults: 🦠 Pan-Genotypic: Effective for Genotypes 1, 2, 3, 4, 5, and 6. 🏥 Liver Status: Used for patients without cirrhosis or with compensated cirrhosis. For decompensated cirrhosis, it is used in combination with Ribavirin. 🛡️ Safety: Safe for HIV/HCV co-infected patients.

Dosage and administration

Packaging: Tablets containing Sofosbuvir 400 mg and Velpatasvir 100 mg. ⚠️ ADMINISTRATION PROTOCOL: 💊 Dose: One tablet taken orally once daily. 🕒 Consistency: Take at the same time every day. 🍲 Usage: Can be taken with or without food. Swallow whole. 📅 Duration: The standard course is 12 weeks (3 bottles) for the vast majority of patients.

Hypersensitivity to active substances. ❤️ Drug Interaction: Co-administration with Amiodarone is contraindicated due to severe bradycardia risk. Pregnancy and breastfeeding. Use with PPIs (Proton Pump Inhibitors) requires caution; do not take simultaneously. Use with strong P-gp inducers (e.g., Rifampin, St. John's Wort).

Velpanex is extremely well-tolerated. Adverse events are usually mild: 🤯 Neurological: Headache. 💤 General: Fatigue. 🤢 Gastrointestinal: Nausea. Most patients maintain their normal daily routine without significant discomfort.

Velpanex — Sofosbuvir 400 mg + 100 mg, 28 pcs, Everest

100% original product

Active ingredient

Sofosbuvir Velpatasvir

Manufacturer

Everest

Dosage 400 mg + 100 mg

Dosage form Tablets

Tablets per pack 28

Velpanex (Sofosbuvir + Velpatasvir) Tablets

Name: Velpanex
Brand: Everest
SKU: PROD-131
Price: 7032 UAH
Availability: InStock

7032₴ ~~7911₴~~ -11%

Velpanex (Sofosbuvir 400 mg + Velpatasvir 100 mg) is a fixed-dose combination pill known as a "pan-genotypic" treatment for Hepatitis C.

Manufacturer: Everest Pharmaceuticals. Each pack contains 28 tablets. It is a generic version of Epclusa.

Key Advantage:

This represents the "Gold Standard" in HCV care. One tablet contains two potent antivirals that target the virus at different stages of its life cycle. It is a single-pill regimen, meaning no other drugs are usually required.

✅ Benefit: Cure rates exceeding 98% across all viral genotypes (1–6), offering a simple and highly effective solution.

Indicated for the treatment of chronic Hepatitis C (CHC) in adults:

🦠 Pan-Genotypic: Effective for Genotypes 1, 2, 3, 4, 5, and 6.
🏥 Liver Status: Used for patients without cirrhosis or with compensated cirrhosis. For decompensated cirrhosis, it is used in combination with Ribavirin.
🛡️ Safety: Safe for HIV/HCV co-infected patients.

Packaging: Tablets containing Sofosbuvir 400 mg and Velpatasvir 100 mg.

⚠️ ADMINISTRATION PROTOCOL:

💊 Dose: One tablet taken orally once daily.
🕒 Consistency: Take at the same time every day.
🍲 Usage: Can be taken with or without food. Swallow whole.
📅 Duration: The standard course is 12 weeks (3 bottles) for the vast majority of patients.

Hypersensitivity to active substances.
❤️ Drug Interaction: Co-administration with Amiodarone is contraindicated due to severe bradycardia risk.
Pregnancy and breastfeeding.
Use with PPIs (Proton Pump Inhibitors) requires caution; do not take simultaneously.
Use with strong P-gp inducers (e.g., Rifampin, St. John's Wort).

Velpanex is extremely well-tolerated. Adverse events are usually mild:

🤯 Neurological: Headache.
💤 General: Fatigue.
🤢 Gastrointestinal: Nausea.
Most patients maintain their normal daily routine without significant discomfort.

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 16.03.2026